EAGLE, Idaho, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has acquired Guardian Hospice and Guardian Hospice of Oklahoma (“Guardian”), which provides skilled hospice services in Grayson, Fannin, Collin, Cook, Denton, and Hunt counties in Texas, and Bryan, Choctaw, Atoka, Pushmataha, Johnston, Coal, Marshall, Murray, Pontotoc, and Love counties in Oklahoma.
“We are very excited to expand the reach of our hospice operations in the states of Texas and Oklahoma,” said Brent Guerisoli, Chief Executive Officer of Pennant. Our strategy of local leaders empowered to meet the needs of local communities has resonated deeply in rural communities across our platform and we look forward to bringing our innovative operating model and high-quality resources to enhance the services offered in these communities.” Mr. Guerisoli added.
“Guardian has a long standing and deep connection in the communities it serves, and we are honored to carry on this legacy of quality care,” said John Gochnour, President and Chief Operating Officer of Pennant, “we are grateful for the trust and welcome that has been extended to us by the wonderful Guardian team of skilled clinicians and compassionate caregivers. We are thrilled to partner with them in delivering life-changing hospice services to residents of these Northern Texas and Southern Oklahoma communities.” added Mr. Gochnour.
Mr. Guerisoli reaffirmed that Pennant continues to pursue opportunities to acquire high quality home health, hospice and senior living businesses throughout the United States.
About Pennant
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 102 home health and hospice agencies and 51 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Last Trade: | US$30.56 |
Daily Change: | -0.58 -1.86 |
Daily Volume: | 266,066 |
Market Cap: | US$923.160M |
November 06, 2024 November 01, 2024 September 30, 2024 August 06, 2024 August 01, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB